Synmosa Biopharma (ROCO:4114) Cash Flow from Discontinued Operations : NT$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Synmosa Biopharma's cash flow from discontinued operations for the three months ended in Mar. 2024 was NT$0 Mil. It means Synmosa Biopharma received NT$0 Mil from the sale of part of business quarterly. Synmosa Biopharma's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0 Mil.

Synmosa Biopharma Cash Flow from Discontinued Operations Historical Data

The historical data trend for Synmosa Biopharma's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma Cash Flow from Discontinued Operations Chart

Synmosa Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Synmosa Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Synmosa Biopharma Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

Synmosa Biopharma Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma (ROCO:4114) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Neihu Road, 11th Floor, No. 396, Taipei, TWN, 114

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products. It provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. Its products concentrate on three therapeutic areas: Cardiovascular, Respiratory, and sex hormone. Its product lines are divided into cold series, nutritional supplement series, gastrointestinal series, skincare series, and hormone series.

Synmosa Biopharma (ROCO:4114) Headlines

No Headlines